Author Archives: admin

Rates of survival increasing for extremely preterm infants, NIH network finds

Among the major findings:

  • Infants born at 23 and 24 weeks survived in greater numbers over the 20-year period. Of those born at 24 weeks, for example, only 52 percent survived in 1993 while 65 percent survived in 2012.
  • A higher number of premature infants survived without major illnesses. For infants born at 27 weeks, for example, survival without major illness increased from 29 percent in 1993 to 47 percent in 2012.
  • For more :

http://www.nih.gov/news/health/sep2015/nichd-08.htm

Fetal ECG readings offer no advantage over heart rate monitoring during labor

“Even though a new treatment or technology may appear promising, it really isn’t possible to know whether it provides any benefits unless it’s tested in a research study,” Dr. Reddy said.  “Our study didn’t find any benefit for ECG ST monitoring in term births.”

http://www.nih.gov/news/health/aug2015/nichd-12a.htm

Morbidity and mortality associated with mode of delivery for breech periviable deliveries

Retrospective cohort study of discharge data for breech deliveries that occurred from 23-24 6/7 weeks’ gestation finds cesarean delivery increased overall survival AND major morbidity for previable breech neonates. However, there was no difference in 6-month survival among intubated neonates , and cesarean delivery did not increase survival for neonates who weighed <500 g

Tucker Edmonds B, et. al., Morbidity and mortality associated with mode of delivery for breech periviable deliveries. Am J Obstet Gynecol. 2015 Jul;213(1):70.e1-70.e12. PMID: 25747545

http://www.ncbi.nlm.nih.gov/pubmed/?term=25747545

Mode of delivery at periviability and early childhood neurodevelopment.

Secondary analysis of the a randomized, controlled trial of Magnesium sulfate for the prevention of cerebral palsy supports obstetric indications should dictate  mode of delivery at 23 4/7 -25 6/7 weeks.

Mode of delivery at periviability and early childhood neurodevelopment.
Običan SG, Small A, Smith D, Levin H, Drassinower D, Gyamfi-Bannerman C.
Am J Obstet Gynecol. 2015 Jun 24. pii: S0002-9378(15)00660-2. doi: 10.1016/j.ajog.2015.06.047. [Epub ahead of print]
PMID: 26116869

Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss

Study finds daily Low-molecular-weight heparin injections do not increase ongoing pregnancy or live-birth rates in women with unexplained RPL
unexplained recurrent pregnancy loss

Schleussner E, et. a., Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme. ETHIG II group.
Ann Intern Med. 2015 May 5;162(9):601-9. doi: 10.7326/M14-2062.
http://www.ncbi.nlm.nih.gov/pubmed/?term=25938990